Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
Trump wants to deploy a hospital ship to Greenland alleging people aren’t receiving care
U.S. President Donald Trump said in a Truth Social post Saturday that he was sending a hospital ship…
What’s next for Novo Nordisk’s obesity drug CagriSema
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
Eli Lilly launches Zepbound obesity drug pen with one month of doses
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March…
Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion
A Gilead Sciences office is shown in Foster City, California, U.S. May 1, 2018. Stephen Lam | Reuters…
Judge orders takeover of health care in Arizona prisons
PHOENIX (AP) — A federal judge has ordered a takeover of health care operations in Arizona’s prisons and…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
Danaher to buy Masimo in $9.9 billion deal in diagnostics push
The Masimo logo is displayed at Masimo headquarters on December 27, 2023 in Irvine, California. Mario Tama |…
Nevada hit with $447K fine for continued delays in mental health care for defendants
Nevada will pay $447,000 in court-ordered fines for continued delays in providing mental health care to criminal defendants…
Pfizer execs talk Metsera obesity drug
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in…
Pfizer’s monthly obesity injection drove shows promise in trial
Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
Eli Lilly CEO David Ricks talks Medicare coverage of obesity pills
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…